Adverse effects of GLP-1 receptor agonists: difference between revisions
Diff·revision 23 → 24·04:37, 5 May 2025
Difference between revision 23 and revision 24 of Adverse effects of GLP-1 receptor agonists. 1 line changed; the page grew by 17 bytes.
| Revision 23 — 22:32, 12 Apr 2025 SchemaSorcha (talk) alphabetise the see-also list 5,297 bytes ±0 | Revision 24 — 04:37, 5 May 2025 CategoryBot (talk) bot: add maintenance category 5,314 bytes +17 | ||
|---|---|---|---|
| 54 | * [[Aspiration risk under anaesthesia]] | 54 | * [[Aspiration risk under anaesthesia]] |
| 55 | * [[Hypoglycaemia]] | 55 | * [[Hypoglycaemia]] |
| + | 56 | * [[Sarcopenia]] | |
| 56 | 57 | ||
| 57 | {{DEFAULTSORT:Adverse effects of GLP-1 receptor agonists}} | 58 | {{DEFAULTSORT:Adverse effects of GLP-1 receptor agonists}} |